These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 1740964)
1. Serum phospholipase A2 enzyme activity and immunoreactivity in a prospective analysis of patients with septic shock. Vadas P; Scott K; Smith G; Rajkovic I; Stefanski E; Schouten BD; Singh R; Pruzanski W Life Sci; 1992; 50(11):807-11. PubMed ID: 1740964 [TBL] [Abstract][Full Text] [Related]
2. Pathogenesis of hypotension in septic shock: correlation of circulating phospholipase A2 levels with circulatory collapse. Vadas P; Pruzanski W; Stefanski E; Sternby B; Mustard R; Bohnen J; Fraser I; Farewell V; Bombardier C Crit Care Med; 1988 Jan; 16(1):1-7. PubMed ID: 3338273 [TBL] [Abstract][Full Text] [Related]
3. Elevated plasma phospholipase A2 levels: correlation with the hemodynamic and pulmonary changes in gram-negative septic shock. Vadas P J Lab Clin Med; 1984 Dec; 104(6):873-81. PubMed ID: 6548766 [TBL] [Abstract][Full Text] [Related]
4. Circulating phospholipase A2 activity associated with sepsis and septic shock is indistinguishable from that associated with rheumatoid arthritis. Green JA; Smith GM; Buchta R; Lee R; Ho KY; Rajkovic IA; Scott KF Inflammation; 1991 Oct; 15(5):355-67. PubMed ID: 1757123 [TBL] [Abstract][Full Text] [Related]
5. Concordance of endogenous cortisol and phospholipase A2 levels in gram-negative septic shock: a prospective study. Vadas P; Pruzanski W; Stefanski E; Ruse J; Farewell V; McLaughlin J; Bombardier C J Lab Clin Med; 1988 May; 111(5):584-90. PubMed ID: 2834477 [TBL] [Abstract][Full Text] [Related]
6. Platelet-activating factor and phospholipase A2 in patients with septic shock and trauma. Sörensen J; Kald B; Tagesson C; Lindahl M Intensive Care Med; 1994 Nov; 20(8):555-61. PubMed ID: 7706567 [TBL] [Abstract][Full Text] [Related]
7. Phospholipase A2 from plasma of patients with septic shock is associated with high-density lipoproteins and C3 anaphylatoxin: some implications for its functional role. Gijón MA; Pérez C; Méndez E; Sánchez Crespo M Biochem J; 1995 Feb; 306 ( Pt 1)(Pt 1):167-75. PubMed ID: 7864806 [TBL] [Abstract][Full Text] [Related]
8. Potential therapeutic efficacy of inhibitors of human phospholipase A2 in septic shock. Vadas P; Stefanski E; Pruzanski W Agents Actions; 1986 Nov; 19(3-4):194-202. PubMed ID: 3825740 [TBL] [Abstract][Full Text] [Related]
9. Involvement of circulating phospholipase A2 in the pathogenesis of the hemodynamic changes in endotoxin shock. Vadas P; Hay JB Can J Physiol Pharmacol; 1983 Jun; 61(6):561-6. PubMed ID: 6883208 [TBL] [Abstract][Full Text] [Related]
10. Induction of circulating group II phospholipase A2 expression in adults with malaria. Vadas P; Keystone J; Stefanski E; Scott K; Pruzanski W Infect Immun; 1992 Sep; 60(9):3928-31. PubMed ID: 1500203 [TBL] [Abstract][Full Text] [Related]
11. A predictive model for the clearance of soluble phospholipase A2 during septic shock. Vadas P; Pruzanski W; Farewell V J Lab Clin Med; 1991 Nov; 118(5):471-5. PubMed ID: 1940588 [TBL] [Abstract][Full Text] [Related]
12. Induction of group II phospholipase A2 expression and pathogenesis of the sepsis syndrome. Vadas P; Pruzanski W Circ Shock; 1993 Feb; 39(2):160-7. PubMed ID: 8490995 [TBL] [Abstract][Full Text] [Related]
14. Are events after endotoxemia related to circulating phospholipase A2? Santos AA; Browning JL; Scheltinga MR; Lynch EA; Brown EF; Lawton P; Chambers E; Dougas I; Benjamin CD; Dinarello CA Ann Surg; 1994 Feb; 219(2):183-92. PubMed ID: 8129489 [TBL] [Abstract][Full Text] [Related]
15. Enzymatic activity and immunoreactivity of extracellular phospholipase A2 in inflammatory synovial fluids. Pruzanski W; Scott K; Smith G; Rajkovic I; Stefanski E; Vadas P Inflammation; 1992 Oct; 16(5):451-7. PubMed ID: 1428121 [TBL] [Abstract][Full Text] [Related]
16. Nitrite/nitrate (NOX) and type II phospholipase A2, leukotriene B4, and platelet-activating factor levels in patients with septic shock. Nakae H; Endo S; Inada K; Yaegashi Y; Takakuwa T; Yamada Y; Arakawa N; Suzuki T; Taniguchi S; Shimamura T; Ogawa M; Teraoka H Res Commun Mol Pathol Pharmacol; 1996 May; 92(2):131-9. PubMed ID: 8774066 [TBL] [Abstract][Full Text] [Related]
17. Selective inhibition of group II phospholipase A2 by quercetin. Lindahl M; Tagesson C Inflammation; 1993 Oct; 17(5):573-82. PubMed ID: 8225564 [TBL] [Abstract][Full Text] [Related]
18. Development and use of ELISA to quantify type II phospholipase A2 in normal and uremic serum. Dorsam G; Harris L; Payne M; Fry M; Franson R Clin Chem; 1995 Jun; 41(6 Pt 1):862-6. PubMed ID: 7768005 [TBL] [Abstract][Full Text] [Related]
19. Enhanced expression of group II phospholipase A2 gene in the tissues of endotoxin shock rats and its suppression by glucocorticoid. Nakano T; Arita H FEBS Lett; 1990 Oct; 273(1-2):23-6. PubMed ID: 2226857 [TBL] [Abstract][Full Text] [Related]
20. Measurement of human phospholipase A2 in arthritis plasma using a newly developed sandwich ELISA. Smith GM; Ward RL; McGuigan L; Rajkovic IA; Scott KF Br J Rheumatol; 1992 Mar; 31(3):175-8. PubMed ID: 1540785 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]